and interferon-ß-1b (IFNß-1b) show a dose-response relationship in multiple sclerosis at current clinical doses. Moreover, the efficacy of these therapies is probably dependent on their frequent ...

are prone to develop multiple sclerosis (MS). The randomized, placebo-controlled CHAMPS trial found early treatment with interferon -1a to be beneficial (Journal Watch Neurology Nov 2 2000); in ...

On the 50th anniversary of the discovery of interferon (IFN), we offer a ... IFNs also proved effectiveness in relapsing, remitting multiple sclerosis. It is now common practice to initiate ...

These changes are more likely if you are taking certain MS medications, like Avonex (interferon beta-1a) or Extavia ...

Inhibiting an immune signaling protein called TLR7 may help preserve the protective layer surrounding nerve fibers in the brain during both Alzheimer's disease and ordinary aging, suggests a study led ...